Public Health and Preventive Medicine

doi: 10.25005/2074-0581-2020-22-1-67-73
MARKETING ASSESSMENT OF DRUGS USED FOR TREATMENT OF ACID-RELATED DISEASES IN BISHKEK

E.B. Murzabaeva, I.Z. Ismailov

Department of Basic and Clinical Pharmacology, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyz Republic

Objective: Marketing assessment of anti-ulcer medicines in pharmacies in Bishkek.

Methods: The study was used by data from the Department of Medicines and Medical Technology at the Ministry of Health of the Kyrgyz Republic on the registration of pharmaceutical products in the KR – State Registry of Medicines and Medical Products of 2019, as well as price sheets and invoices of wholesale pharmaceutical companies and retail pharmacies in Bishkek.

Results: Depending on the value of the turnover rate (TR), the drugs were divided into three groups: drugs with slow TR (0.5 < К < 1.0); drugs with constant TR (0.26 < К < 0.49); drugs with high TR (0 < К < 0.25). According to the results of studies, proton pump inhibitors and colloidal bismuth-based drugs are high-end drugs of TR.

Conclusion: We have determined that the pharmaceutical market in Bishkek demonstrates incomplete saturation of anti-ulcer drugs from the total number of registered medicines. At the same time, the largest part of the range are drugs from the group of proton pump inhibitors.

Keywords: Anti-ulcer drugs, proton pump inhibitors, marketing assessment, turnover rate.

Download file:


References
  1. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390:613-24.
  2. Soreide K, Thorsen K, Harrison E.M, Bingener J, Moller MH, Ohene-Yeboah M, et al. Perforated peptic ulcer. Lancet. 2015;386:1288-98.
  3. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-71.
  4. Natsional’nyy statisticheskiy komitet Kyrgyzskoy Respubliki [National statistical committee of Kyrgyz Republic] [Elektronniy resurs]. 2019. Rezhim dostupa: http://www.stat.kg/ru/statistics/zdravoohranenie/.
  5. Peptic ulcer disease medication. MedScape; 2019. Available from: https:// emedicine.medscape.com/article/181753-medication.
  6. Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, et al. Efficacy and safety of proton-pump inhibitors in high-risk cardiovascular subsets of the COGENT Trial. Am J Med. 2016;129(9):1002-5.
  7. Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, et al. Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy. J Am Coll Cardiol. 2016;67(14):1661-71.
  8. Malfertheiner P, Megraud F, O’Morain C, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus. Report. Gut. 2017;66(1):6-30.
  9. Sugano К, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353- 67.
  10. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51-69.
  11. Moldobaeva VS, Tolombaeva NT, Attokurova RM, Zurdinova AA, Elistratov AA, Zhalilova BS. Klinicheskoe rukovodstvo po diagnostike i lecheniyu neoslozhnyonnoy yazvennoy bolezni v aktivnoy faze na pervichnom urovne zdravookhraneniya Kyrgyzskoy Respubliki [Clinical guidelines for the diagnosis and treatment of uncomplicated peptic ulcer in the active phase at the primary level of healthcare of the Kyrgyz Republic]. Bishkek, KR: 2010. 77 p.
  12. Global peptic ulcer drugs market – forecast to 2022. Market Research Future; 2019. Available from: https://www.marketresearchfuture.com/reports/peptic-ulcer-drugs-market-2445.
  13. Global market study on peptic ulcer drugs: North America to lead in global market during forecast period 2016-2022, driven by increasing NSAID consumption. Persistence Market Research; 2019. Available from: https://www. persistencemarketresearch.com/market-research/peptic-ulcer-drugs-market.asp.
  14. Peptic ulcer drugs market 2019: Opportunities, trends, and forecast by 2024 – market research engine. Market Watch; 2019. Available from: https://www. marketwatch.com/press-release/peptic-ulcer-drugs-market-2019-opportunities-trends-and-forecast-by-2024---market-research-engine-2019-06-20.
  15. The Top 200 of 2019. ClinCalc DrugStats Database; 2019. Available from: https://clincalc.com/DrugStats/Top200Drugs.aspx.
  16. Fuentes AV, Pineda MD, Nagulapalli KC. Venkata comprehension of Top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy. 2018;6(2):43.
  17. Gosudarstvennyy reestr LS i IMN [State register of drugs and medical devices] [Elektronnyy resurs]. 2019. Rezhim dostupa: http://212.112.103.101/reestr.
  18. Ismailov IZ. Marketingovye issledovaniya lekarstvennykh preparatov gruppy immunomodulyatorov v Kyrgyzskoy Respublike [Marketing research of drugs from the immunomodulator group in the Kyrgyz Republic]. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy. 2016;8(5):764-6.

Author information:


Murzabaeva Elvira Bolotbekovna
Postgraduate Student, Department of Basic and Clinical Pharmacology, I.K. Akhunbaev Kyrgyz State Medical Academy
ORCID ID: 0000-0002-5258-9879
SPIN: 9282-8743
E-mail: elusya_kg@mail.ru

Ismailov Isabek Zaylidinovich
Doctor of Pharmaceutical Sciences, Associate Professor, Department of Basic and Clinical Pharmacology, I.K. Akhunbaev Kyrgyz State Medical Academy
Researcher ID: B-7280-2017
SCOPUS: 57189622130
ORCID ID: 0000-0003-4980-8986
Author ID: 805452
SPIN: 7650-2129
E-mail: ism-isa@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Ismailov Isabek Zaylidinovich
Doctor of Pharmaceutical Sciences, Associate Professor, Department of Basic and Clinical Pharmacology, I.K. Akhunbaev Kyrgyz State Medical Academy

720020, Kyrgyz Republic, Bishkek, Akhunbaev Street, 92

Tel.: +996 (559) 639777

E-mail: ism-isa@mail.ru

Materials on the topic: